title: Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.
abstract: Both human immunodeficiency virus (HIV) and illicit drug addiction remain major health problems not only in the United States but all over globe. The effect of drug addiction on HIV/AIDS (acquired immunodeficiency syndrome) has been somewhat underexplored. However, in United States more than one fourth of HIV-positive individuals are injection drug users. Opiates are known to negatively affect the immune system, and therefore may have deleterious effects on progression of disease among HIV-infected individuals. This review discusses the effects of opiates on immune system as well as its effect on HIV replication and AIDS progression. In addition, the effects of opiates on disease progression in non-human primate model of AIDS is presented with at least one possible reason for rapid disease progression in multi-virus the challenge model.
authors.affiliation: Ponce School of Medicine, Ponce, Puerto Rico.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Noel
authors.forename: Vanessa
authors.initials: V
authors.lastname: Rivera-Amill
authors.forename: Shilpa
authors.initials: S
authors.lastname: Buch
authors.forename: Anil
authors.initials: A
authors.lastname: Kumar
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000503:physiopathology / Q000821:virology; D000818:Animals; D004195:Disease Models, Animal; D018450:Disease Progression; D007107:Immune System / Q000187:drug effects* / Q000821:virology*; D009294:Narcotics / Q000494:pharmacology; D009293:Opioid-Related Disorders / Q000150:complications; D011323:Primates / Q000821:virology*
chemical_list: D009294:Narcotics
references.citation: Adv Exp Med Biol. 1993;335:35-9
references.pmid: 8237605
references.citation: J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91
references.pmid: 18040783
references.citation: AIDS Res Hum Retroviruses. 2006 Aug;22(8):817-23
references.pmid: 16910840
references.citation: Front Biosci. 2005 May 01;10:1666-77
references.pmid: 15769657
references.citation: J Virol. 2000 Dec;74(24):11858-72
references.pmid: 11090186
references.citation: Virology. 2006 Mar 1;346(1):127-38
references.pmid: 16313937
references.citation: J Pharmacol Exp Ther. 2003 Dec;307(3):1158-62
references.pmid: 14560041
references.citation: Am J Ther. 2004 Sep-Oct;11(5):354-65
references.pmid: 15356431
references.citation: Biochem Biophys Res Commun. 1993 Sep 30;195(3):1165-73
references.pmid: 8216245
references.citation: Adv Exp Med Biol. 2003;521:98-105
references.pmid: 12617568
references.citation: Virology. 2006 Jun 5;349(2):440-52
references.pmid: 16643974
references.citation: J Leukoc Biol. 2005 Sep;78(3):772-6
references.pmid: 16000393
references.citation: Virology. 2007 Feb 20;358(2):373-83
references.pmid: 17011009
references.citation: J Virol. 2004 Oct;78(20):11425-8
references.pmid: 15452267
references.citation: J Infect Dis. 2000 Apr;181(4):1350-8
references.pmid: 10762566
references.citation: Adv Exp Med Biol. 2001;493:127-35
references.pmid: 11727758
references.citation: Virology. 2006 Oct 10;354(1):192-206
references.pmid: 16876224
references.citation: Adv Exp Med Biol. 1995;373:1-9
references.pmid: 7668139
references.citation: Neurology. 1998 Jun;50(6):1814-20
references.pmid: 9633733
references.citation: Adv Exp Med Biol. 1993;335:21-8
references.pmid: 8237597
references.citation: J Neuroimmunol. 2004 Apr;149(1-2):90-100
references.pmid: 15020069
references.citation: J Virol. 1998 May;72(5):4478-84
references.pmid: 9557745
references.citation: Science. 1995 Nov 10;270(5238):988-91
references.pmid: 7481804
references.citation: J Investig Med. 2002 Nov;50(6):435-42
references.pmid: 12425430
references.citation: J Acquir Immune Defic Syndr. 2002 Oct 1;31 Suppl 2:S78-83
references.pmid: 12394786
references.citation: J Neuroimmune Pharmacol. 2008 Mar;3(1):12-25
references.pmid: 18247128
references.citation: J Neuroimmunol. 1998 Mar 15;83(1-2):77-87
references.pmid: 9610676
references.citation: J Infect Dis. 2002 Jan 1;185(1):118-22
references.pmid: 11756991
references.citation: J Neuroimmunol. 1994 Mar;50(2):167-75
references.pmid: 8120138
references.citation: AIDS. 1990 Sep;4(9):869-73
references.pmid: 2174676
references.citation: J Infect Dis. 2002 Jun 15;185(12):1826-9
references.pmid: 12085334
references.citation: FEMS Immunol Med Microbiol. 2006 Aug;47(3):330-42
references.pmid: 16872369
references.citation: Brain. 1998 Nov;121 ( Pt 11):2043-52
references.pmid: 9827765
references.citation: Adv Exp Med Biol. 1996;402:43-51
references.pmid: 8787642
references.citation: Clin Infect Dis. 2005 Oct 1;41(7):1027-34
references.pmid: 16142670
references.citation: AIDS Res Hum Retroviruses. 2006 Jan;22(1):114-9
references.pmid: 16438654
references.citation: Pediatr Res. 2003 Aug;54(2):282-8
references.pmid: 12736382
references.citation: Crit Rev Immunol. 1996;16(2):109-44
references.pmid: 8879941
references.citation: AIDS Res Hum Retroviruses. 2004 Jun;20(6):684-6
references.pmid: 15242547
references.citation: Virology. 2002 Mar 30;295(1):133-46
references.pmid: 12033772
references.citation: Virology. 2007 Mar 15;359(2):397-404
references.pmid: 17064752
references.citation: Cell. 1991 May 17;65(4):651-62
references.pmid: 2032289
references.citation: AIDS. 1994 Mar;8(3):339-43
references.pmid: 7913328
references.citation: Adv Exp Med Biol. 1993;335:181-8
references.pmid: 8237594
references.citation: J Pharmacol Exp Ther. 1993 Oct;267(1):9-15
references.pmid: 7693915
references.citation: J Virol. 1998 Mar;72(3):2509-15
references.pmid: 9499115
references.citation: Proc Natl Acad Sci U S A. 1998 May 26;95(11):6326-30
references.pmid: 9600964